Dr. Kamakshi Memorial Hospital

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

Andrew J.S. Coats, Venkatesan Srinivasan, J Surendran et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 59 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Metronomic Chemotherapy +19

Evaluating the radioprotective effect of hesperidin in the liver of Swiss albino mice

Kalpana K. Bhanumathy, Devipriya Nagarajan, Srinivasan Marimuthu et al. · European Journal of Pharmacology · 2011 · 59 citations

Swiss Albino Mice, Hepatology, Medicine +14

Diet and inflammatory bowel disease: The Asian Working Group guidelines

Ajit Sood, Vineet Ahuja, Saurabh Kedia et al. · Indian Journal of Gastroenterology · 2019 · 54 citations · Full text

Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy

Umesh Mahantshetty, Shivakumar Gudi, Roshni Singh et al. · Journal of Contemporary Brachytherapy · 2019 · 47 citations · Full text

ADXS11-001 immunotherapy targeting HPV-E7: Final results from a phase 2 study in Indian women with recurrent cervical cancer.

Partha Basu, Ajay Mehta, Minish Jain et al. · Journal of Clinical Oncology · 2014 · 32 citations

Immunodeficiencies, Immunology, Immunoediting +25